The International Congress of Parkinson’s Disease and Movement Disorders® took place from 27th-31st August 2023 in Copenhagen, Denamark.

The meeting featured an impressive program of sessions covering the latest advancements and research in the field of movement disorders.

VJNeurology covered the congress to bring you exclusive content on the greatest scientific and clinical developments.

View all videos

MDS 2023

The International Congress of Parkinson’s Disease and Movement Disorders® took place from 27th-31st August 2023 in Copenhagen, Denamark.

The meeting featured an impressive program of sessions covering the latest advancements and research in the field of movement disorders.

VJNeurology covered the congress to bring you exclusive content on the greatest scientific and clinical developments.

View all videos

Latest videos from MDS 2023

View all

2:24

Growing controversies and advancements in movement disorders care

Francisco Cardoso • 28 Aug 2023

1:15

The impact of genetics on Parkinson’s disease diagnosis and treatment options

Prashanth Kukkle • 27 Aug 2023

2:02

Transparency and regulation in transplant studies in movement disorders

Cindy Towns • 29 Aug 2023

1:09

Shifting the focus on Parkinson’s disease research: looking beyond the dopamine deficit

Santiago Perez Lloret • 27 Aug 2023

Scientific developments

View all

3:01

The value of alpha-synuclein as a putative target for therapeutic intervention in synucleinopathies

Tiago Outeiro • 28 Aug 2023

7:59

Exploring genetic testing in Parkinson’s disease

Jonathan Carr • 23 Aug 2023

Diagnosing movement disorders

View all

3:31

Challenges faced in the clinical assessment of non-motor features in Parkinson’s disease

K. Ray-Chaudhuri • 29 Aug 2023

2:50

Controversies surrounding the definition and staging of Parkinson’s disease

Francisco Cardoso • 28 Aug 2023

Management of Movement Disorders

View all

1:56

Exploring palliative care for movement disorders

Victor McConvey • 27 Aug 2023

2:45

Should on-demand treatments for Parkinson’s disease OFF episodes be used earlier?

Stuart Isaacson • 29 Aug 2023

Trial Updates

View all

2:30

Phase II study of risvodetinib in Parkinson’s disease

Milton Werner • 29 Aug 2023

2:53

PADOVA study: prasinezumab in patients with early Parkinson’s disease

Tania Nikolcheva • 29 Aug 2023